Resection improves survival rate in advanced melanoma cases

04/16/2013 | SkinAndAllergyNews.com

Patients with advanced melanoma treated with surgical resection along with the drug ipilimumab had a 5-year melanoma-specific survival rate of 51% and a median overall survival duration of 60 months, according to researchers at the John Wayne Cancer Institute in Santa Monica, Calif. A 2012 study found a 7% survival rate for advanced melanoma patients treated with systemic medical therapy alone.

View Full Article in:

SkinAndAllergyNews.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Actuary
Meridian Health Plan
Detroit, MI
Director, Payer Marketing
Avalere Health
Washington, DC
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX